Grant: CIHR Café Scientifique Program - Institute of Cancer Research
Ottawa Hospital Research Institute
$3,945.00
Bringing Cancer Research from Bench to Bedside
EF 2022-23
Résumé
Our café scientifique is designed to be an informal and interactive event where our panelists, consisting of trainees, researchers and medical doctors, will showcase their research and engage with the cancer patients and their families. The major focus will be comminicating current immunotherapies available for cancer treatment. Patients will hear from experts in the field, who will take this opportunity to explain their research in simple terms, providing a clear and accessible overview of the latest developments in immunotherapy. Patients will also have the opportunity to ask questions, share their experiences, and learn more about how immunotherapies could potentially benefit them.
Programme
CIHR Café Scientifique Program - Institute of Cancer Research
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Other
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
485596
Name
Dave Jaahnavi
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Special Cases
Projecttitle
Bringing Cancer Research from Bench to Bedside
Programtype2
Miscellaneous Programs
Orgnameinp2
Ottawa Hospital Research Institute
Cihramount2
$3,945
Cihrequipment2
$0
Programname2
CIHR Café Scientifique Program - Institute of Cancer Research
Keyworddelim
Cancer Treatment; Immunotherapies; Knowledge Dissemination
Abstract
Our café scientifique is designed to be an informal and interactive event where our panelists, consisting of trainees, researchers and medical doctors, will showcase their research and engage with the cancer patients and their families. The major focus will be comminicating current immunotherapies available for cancer treatment. Patients will hear from experts in the field, who will take this opportunity to explain their research in simple terms, providing a clear and accessible overview of the latest developments in immunotherapy. Patients will also have the opportunity to ask questions, share their experiences, and learn more about how immunotherapies could potentially benefit them.
Competitiondate
202303
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dave, Jaahnavi; Auer, Rebecca Ann C
Approvedterm
1 an 0 mois
Cihrcontribution2
ICR~ $3,945~ $0~